SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor interest driven by strong Q4 earnings, reduced debt, and a strategic pivot toward domestic pharmaceutical manufacturing and advanced materials. The community is actively discussing the stock's potential for a "short squeeze" and speculating on upcoming regulatory catalysts, while debating the company's valuation as it works to solidify its role in the U.S. supply chain.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing heavy volatility as traders debate the sustainability of its parabolic rally following its S&P 500 inclusion and massive AI-driven infrastructure demand. The community is sharply divided between bulls citing mission-critical optical networking bottlenecks and bears warning of a potential liquidity trap or bubble valuation.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

KELYB is seeing intense community activity driven by its extremely low float, which investors believe creates the potential for rapid volatility and short squeezes. Traders are closely monitoring upcoming investor calls and the influence of major institutional positions, with many debating whether the current price action represents a temporary pullback or a setup for further gains.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the focal point of intense market volatility, driven by a combination of disappointing quarterly delivery figures, broader geopolitical instability in the Middle East, and active investor speculation regarding the company's valuation as a proxy for Elon Musk's wider ventures, including the upcoming SpaceX IPO. Community sentiment is deeply polarized, with traders aggressively debating whether to treat the stock as a distressed automotive manufacturer or a long-term play on AI and robotics, while many are actively using options to hedge or capitalize on the heightened price fluctuations.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The SPY is currently trading in a highly volatile, news-driven environment where investors are attempting to reconcile a significant spike in oil prices with a resilient equity market. Market participants remain deeply divided and cautious, with heavy debate focusing on whether the current price action is a genuine reversal or a manipulative bull trap designed to liquidate option premiums ahead of the long holiday weekend.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy ($RAGE) is trending as the community doubles down on "OG meme" culture, driven by the restoration of classic comic-making tools on the Solana blockchain. Investors are emphasizing high-conviction "bag holding" and long-term building as they contrast their project's historical cultural relevance against what they describe as short-lived, "forced" meme tickers.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is rallying as the space sector gains momentum ahead of the Artemis II mission launch, with investors closely watching for impact on the broader orbital infrastructure market. The community remains highly active, debating the potential for a short squeeze while contrasting current mission optimism against lingering concerns over share offerings.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is experiencing intense volatility driven by conflicting signals between rising oil prices and algorithmic buying, leading to significant friction between bearish sentiment over geopolitical instability and bullish institutional accumulation. Community discussion is dominated by intense frustration over market manipulation, with retail traders debating whether the rapid price swings represent a sustainable rally or a deceptive trap ahead of the upcoming holiday weekend.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is surging as geopolitical tensions intensify following a recent presidential address that signaled a prolonged military conflict with Iran, dashing market hopes for a de-escalation. The community is actively debating the potential for long-term oil supply disruptions, with many traders monitoring the Strait of Hormuz for toll-related developments while gauging the sustainability of the price move amidst warnings of a wider economic slowdown.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is attracting significant community attention due to its position as a high-volatility, low-float stock within the space sector, with traders actively debating its potential for a short squeeze amid speculation surrounding the highly anticipated SpaceX IPO. While some investors are bullish on the company's aerospace R&D partnerships and potential for supersonic flight testing, others are aggressively raising red flags regarding the recent CEO resignation, lack of current revenue, and the risk of future share dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and...

ImmunityBio (NASDAQ:IBRX) Trading Down 6.9% - Here's Why

ImmunityBio (NASDAQ:IBRX) Stock Price Down 6.9% - Here's What Happened...

ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman

ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages ImmunityBio, Inc. (IBRX) Shareholders To Inquire About Securities Fraud Class Action

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or...

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Violated FDA Drug Rules: Levi & Korsinsky

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Violated FDA Drug Rules: Levi & Korsinsky IBRX Investor...

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Deadline in Securities Fraud Class Action Lawsuit Contact Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against...

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

IBRX Stock Notches Strongest Quarter Ever — But These 2 Smaller Biotech Plays Ran Even Hotter

IBRX surged 287% in the latest quarter, marking its strongest quarterly performance on record, but ANL rose 387% and ERAS gained 335%.

Equity

ImmunityBio (NASDAQ:IBRX) Shares Up 15.2% - What's Next?

ImmunityBio (NASDAQ:IBRX) Stock Price Up 15.2% - Here's What Happened...

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Chairman Allegedly Misbranded Cancer Drug: Levi & Korsinsky

Institutional investors holding positions in ImmunityBio, Inc. (NASDAQ: IBRX) during the period January 19, 2026 through March 24, 2026 may wish to evaluate lead plaintiff opportunities in a pending...

INVESTOR ALERT: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit

INVESTOR ALERT: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit INVESTOR ALERT: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit PR Newswire SAN DIEGO...

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Investors are optimistic about the Phase 3 clinical trial announcement targeting severe sepsis and pneumonia as a high-potential revenue driver.

Long-term believers are actively calling out short-sellers and institutional market makers for allegedly suppressing the stock price through volatility.

The company’s recent $100 million non-dilutive financing deal is being viewed by supporters as a critical step for global expansion and balance sheet health.

Optimists point to ongoing activities at the Dunkirk facility and related job postings as evidence of scaling production for future label expansions.

Shareholders are voicing frustration over perceived bureaucratic obstacles from the FDA and potential conflicts regarding misleading promotional claim warnings.

IBRX
ImmunityBio Inc

Feed

News

Sentiment

Fundamentals

Info

Latest IBRX News

IBRXImmunityBio Inc